Literature DB >> 30003139

Prevalence and Genotypes of Parvovirus B19 Among HIV Positive Children in Ibadan, Oyo State, Nigeria.

B O Aleru1, B A Olusola1, A O Faneye1, G N Odaibo1, D O Olaleye1.   

Abstract

Human Parvovirus B19 (B19V) is a global infection with over 50% of infected children residing in sub-Saharan Africa. It causes persistent anaemia under immuno-compromised states such as HIV infection, thereby complicating the course of HIV infection. This study was therefore designed to determine the prevalence and genotypes of B19V among HIV positive children. Blood specimens were collected from HIV positive children and genomic DNA extracted and assayed for the presence of Parvovirus B19 DNA using polymerase chain reaction and the product detected by gel electrophoresis. Amplicons for positive PCR were purified and sequenced for genotype analysis. For the purpose of comparison (differences in the sequences of the NS1/VP1u region), nine HIV negative children were enrolled in this study. Two (1.3%) of the 158 HIV infected children were positive for Parvovirus B19 DNA. Analysis of the results showed a low prevalence of Parvovirus B19 among HIV positive children but a significant relationship was established between Parvovirus B19 infection and the severity of anaemia (p=0.015). Phylogenetic analysis of the sequence data showed that all the B19 virus isolates detected in this study were genotype 1. This study therefore has been able to give an insight to the prevalence and circulating genotypes of Parvovirus B19 among HIV infected children and also establishing a relationship between anaemia and parvovirus B19 infection.

Entities:  

Keywords:  Anaemia; Genotype; HIV; Parvovirus B19

Year:  2018        PMID: 30003139      PMCID: PMC6039191     

Source DB:  PubMed          Journal:  Arch Basic Appl Med        ISSN: 2360-9680


  10 in total

Review 1.  Challenges of malnutrition care among HIV-infected children on antiretroviral treatment in Africa.

Authors:  J Jesson; V Leroy
Journal:  Med Mal Infect       Date:  2015-04-07       Impact factor: 2.152

2.  No evidence of persistent parvovirus B19 viremia among Iranian patients with HIV after a 1-year follow-up.

Authors:  Arezoo Aghakhani; Minoo Mohraz; Kayhan Azadmanesh; Saeedeh Moayedi-Nia; Monireh Kazemimanesh; Setareh Mamishi; Mohammad Banifazl; Amitis Ramezani
Journal:  Arch Virol       Date:  2016-02-10       Impact factor: 2.574

3.  Frequency and genotype of human parvovirus B19 among Iranian patients infected with HIV.

Authors:  Kayhan Azadmanesh; Minoo Mohraz; Monireh Kazemimanesh; Arezoo Aghakhani; Maryam Foroughi; Mohammad Banifazl; Ali Eslamifar; Amitis Ramezani
Journal:  J Med Virol       Date:  2015-03-13       Impact factor: 2.327

4.  Nutritional Status and Other Baseline Predictors of Mortality among HIV-Infected Children Initiating Antiretroviral Therapy in Tanzania.

Authors:  Ramadhani S Mwiru; Donna Spiegelman; Christopher Duggan; George R Seage; Helen Semu; Guerino Chalamilla; Rodrick Kisenge; Wafaie W Fawzi
Journal:  J Int Assoc Provid AIDS Care       Date:  2013-10-08

Review 5.  B19 virus genome diversity: epidemiological and clinical correlations.

Authors:  Giorgio Gallinella; Simona Venturoli; Elisabetta Manaresi; Monica Musiani; Marialuisa Zerbini
Journal:  J Clin Virol       Date:  2003-09       Impact factor: 3.168

6.  Phylogenetic analysis of human parvovirus b19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b.

Authors:  Judith M Hübschen; Zefira Mihneva; Andreas F Mentis; François Schneider; Yair Aboudy; Zehava Grossman; Hagit Rudich; Kalia Kasymbekova; Inna Sarv; Jasminka Nedeljkovic; Marc C Tahita; Zekiba Tarnagda; Jean-Bosco Ouedraogo; A G Gerasimova; T N Moskaleva; Nina T Tikhonova; Nazibrola Chitadze; J C Forbi; Adedayo O Faneye; Jesse A Otegbayo; Emilie Charpentier; Claude P Muller
Journal:  J Clin Microbiol       Date:  2009-09-09       Impact factor: 5.948

7.  Insights into epidemiology of human parvovirus B19 and detection of an unusual genotype 2 variant, Bulgaria, 2004 to 2013.

Authors:  Stefka Krumova Ivanova; Zafira Georgieva Mihneva; Andon Krumov Toshev; Valentina Pavlova Kovaleva; Lubena Georgieva Andonova; Claude P Muller; Judith M Hübschen
Journal:  Euro Surveill       Date:  2016

8.  Clinical features and laboratory findings of human parvovirus B19 in human immunodeficiency virus-infected patients.

Authors:  Renata Freire Alves Pereira; Rita de Cássia Nasser Cubel Garcia; Kátia Martins Lopes de Azevedo; Sérgio Setúbal; Marilda Agudo Mendonça Teixeira de Siqueira; Solange Artimos de Oliveira
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-04       Impact factor: 2.743

9.  Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013.

Authors:  Désiré L Dahourou; Madeleine Amorissani-Folquet; Malik Coulibaly; Divine Avit-Edi; Nicolas Meda; Marguerite Timite-Konan; Vic Arendt; Diarra Ye; Clarisse Amani-Bosse; Roger Salamon; Philippe Lepage; Valériane Leroy
Journal:  J Int AIDS Soc       Date:  2016-03-23       Impact factor: 5.396

10.  Co-infection of human parvovirus B19 with Plasmodium falciparum contributes to malaria disease severity in Gabonese patients.

Authors:  Nguyen L Toan; Bui T Sy; Le H Song; Hoang V Luong; Nguyen T Binh; Vu Q Binh; Reinhard Kandolf; Thirumalaisamy P Velavan; Peter G Kremsner; C-Thomas Bock
Journal:  BMC Infect Dis       Date:  2013-08-15       Impact factor: 3.090

  10 in total
  1 in total

1.  Parvovirus B19 DNA detection in treatment-naïve HIV anemic patients in Lagos, Nigeria: a case control study.

Authors:  Oluwaseyi Sedowhe Ashaka; Olumuyiwa Babalola Salu; Ayorinde Babatunde James; Akeeb Oriowo Bola Oyefolu; AbdulAzeez Adeyemi Anjorin; Bamidele Oludare Oke; Mercy Remilekun Orenolu; Sunday Aremu Omilabu
Journal:  Afr Health Sci       Date:  2020-03       Impact factor: 0.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.